Pseudomonas aeruginosa reference strains PAO1 and PA14: A genomic, phenotypic, and therapeutic review

A Grace, R Sahu, DR Owen, VA Dennis - Frontiers in Microbiology, 2022 - frontiersin.org
Pseudomonas aeruginosa is a ubiquitous, motile, gram-negative bacterium that has been
recently identified as a multi-drug resistant pathogen in critical need of novel therapeutics. Of …

Total synthesis, structure elucidation and expanded bioactivity of icosalide A: effect of lipophilicity and ester to amide substitution on its bioactivity

A Dangi, B Pande, S Agrawal, D Sarkar… - Organic & …, 2023 - pubs.rsc.org
The first total synthesis of icosalide A, an antibacterial depsipeptide that is unique in that it
contains two lipophilic beta-hydroxy acids, has been achieved by following Fmoc solid …

Biodistribution and toxicity of innate defense regulator 1018 (IDR-1018)

TVF Esposito, C Rodriguez-Rodriguez… - European journal of …, 2022 - Elsevier
Innate defense regulators (IDRs) are synthetic host-defense peptides (HDPs) with broad-
spectrum anti-infective properties, including immunomodulatory, anti-biofilm and direct …

Host Defense Peptides: Multifront Attack on Biofilms

M Dostert, L Pedraz, REW Hancock - Antibiofilm Strategies: Current and …, 2022 - Springer
Short, cationic, amphipathic peptides are found as natural antimicrobial agents among all
life forms. These natural peptides and their synthetic analogs, collectively named host …

[PDF][PDF] Pharmacokinetics of Cationic Host-Defense Peptides and Innate Defense Regulators in Native and Formulated States

TVF Esposito - 2022 - open.library.ubc.ca
Nature presents a solution to drug resistant infections in the form of cationic host defense
peptides (CHDPs), such as LL-37, that exhibit wide-ranging antimicrobial, anti-biofilm, and …

[PDF][PDF] NtrBC selectively regulates adaptation and intercellular interactions of Pseudomonas aeruginosa

MA Alford - 2022 - open.library.ubc.ca
Pseudomonas aeruginosa is an opportunistic pathogen that causes nosocomial and chronic
infections contributing to morbidity and mortality in skin wound and cystic fibrosis patients …